Hormonal contraception, such as the pill, ring, or patch, offers numerous benefits for women, including effective pregnancy prevention and additional health advantages. However, for some individuals, there are potential trade-offs, as side effects—ranging from mild to serious—can occur. Each person's experience is unique, with risks influenced by factors like age, genetics, and pre-existing medical conditions. Choosing a contraceptive method is an important decision that should be made in consultation with a gynecologist to carefully evaluate the benefits and risks. Fortunately, a wide range of contraceptive options exists, and it is often possible to switch methods if needed. One area of concern is the potential link between hormonal contraceptives and cancer risk. According to the Vidal website, oral contraceptives containing both estrogen and progestin may increase the risk of breast, cervical, and liver cancers, particularly for younger users. However, they are associated with a reduced risk of ovarian and endometrial cancers. This increased risk of breast cancer tends to diminish over time, returning to normal levels after about ten years of stopping use. Hormonal contraceptives can also affect the circulatory system, increasing the risk of blood clots. In France, twelve women die each year from heart attacks or strokes linked to these contraceptives, representing about 2% of thromboembolic events caused by estrogen-containing methods. Estrogens in these contraceptives can promote the formation of blood clots in veins or arteries. The risk varies depending on the type of progestin used. For example, second-generation progestins like levonorgestrel are associated with a lower risk of blood clots compared to third- or fourth-generation options such as desogestrel, gestodene, or drospirenone. The risk of blood clots is influenced by both an individual's medical history and the specific composition of the contraceptive. For example, estrogen-progestin contraceptives are generally contraindicated for individuals with a family history of early heart attacks or strokes, hypertension, or certain types of diabetes. Similarly, they are not recommended for those with known blood clotting disorders or a family history of venous thromboembolism. However, these contraceptives also offer significant health benefits, including a reduced risk of endometrial, ovarian, and colon cancers, as well as more regular menstrual cycles, reduced premenstrual symptoms, and improved pain management for endometriosis. Despite concerns about weight gain, research suggests that the pill does not typically cause significant weight gain. While estrogens may lead to water retention and cellulite, these effects are generally not noticeable at the low doses found in contraceptive pills. If weight gain is a concern, alternatives such as lower-dose pills or progestin-only contraceptives may be considered. Regarding libido, while androgen hormones are more closely linked to sexual desire, the estrogens and progesterone in the pill are not directly responsible for changes in libido. Psychological factors also play a significant role in sexual desire, and the use of contraception can influence these aspects as well.